Updates
** Medical device maker Becton Dickinson's BDX.N shares fall 3.7% to $169.89 premarket
** Co's quarterly revenue of $5.89 billion misses analysts' average expectation of $5.90 billion - data compiled by LSEG
** Reports Q4 adj. profit of $3.96/shr vs estimates of $3.92/shr
** BDX now expects 2026 adjusted profit between $14.75 and $15.05/shr, compared with estimates of $14.84/shr
** Up to last close, stock down ~23% YTD
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))